Combination Therapy for Recurrent Ovarian Cancer

NCT05610735 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Ovarian Cancer

Interventions

DRUG: DOXIL
DRUG: Withaferin A
DRUG: Ashwagandha
DRUG: Combination of ASWD and DOXIL

Sponsor

Sham Sunder Kakar

Collaborators

[object Object]